
The Medical Research Council (MRC) has awarded £3.7 million to develop a new centre aimed at reducing the risks of adverse drug effects. Scientists at the Universities of Liverpool and Manchester will work with leading pharmaceutical companies to improve understanding of adverse drug reactions and investigate how to improve the design, tailoring and selection of drugs.
Click here for full Story http://www.medicalnewstoday.com/articles/125284.php |